Atlas Trials

Tolerance and Potential Synergistic Effect of the Combination of Intranasal Esketamine and Non-selective MAOI

Clinical trial NCT05530668 · COMPLETED

Trial details

NCT number
NCT05530668
Sponsor
University Hospital, Strasbourg, France
Status
COMPLETED
Study type
OBSERVATIONAL
Depression Anxiety Disorder
Start date
2022-04-11
Primary completion
2022-09-11
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.